APA (7th ed.) Citation

Zhao, Q., Yuan, Y., Xu, T., Yan, N., Li, F., Lu, J., . . . Yan, Z. Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: A real-world retrospective study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhao, Qi, Yusen Yuan, Tongxin Xu, Ningning Yan, Fei Li, Juntao Lu, Ming He, and Zhaoyang Yan. Perioperative Outcomes of Neoadjuvant Chemotherapy Plus Camrelizumab Versus Neoadjuvant Chemotherapy Plus Tislelizumab for Locally Advanced Esophageal Squamous Cell Cancer: A Real-world Retrospective Study. Frontiers Media S.A.

MLA (9th ed.) Citation

Zhao, Qi, et al. Perioperative Outcomes of Neoadjuvant Chemotherapy Plus Camrelizumab Versus Neoadjuvant Chemotherapy Plus Tislelizumab for Locally Advanced Esophageal Squamous Cell Cancer: A Real-world Retrospective Study. Frontiers Media S.A.